Cite
HARVARD Citation
Planagumà, A. et al. (n.d.). Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Pulmonary pharmacology & therapeutics. pp. 37-45. [Online].